Registry of Endovascular Treatment for Vertebrobasilar Dissecting Aneurysms in China

Launched by BEIJING TIANTAN HOSPITAL · Aug 2, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a condition called vertebrobasilar dissecting aneurysms (VBDAs), which are a type of blood vessel problem in the brain that can lead to strokes, especially in younger people. The researchers want to better understand how different treatments, such as careful observation or specific medical procedures, can help patients with this condition. They are looking for individuals aged 18 to 80 who have been diagnosed with an unruptured (not burst) aneurysm and have had the necessary brain scans.

Participants in this study will be closely monitored, and their treatment options will be tailored to their individual needs. They may be placed in one of three groups: those who will be observed, those who will receive a stent to help support the blood vessel, or those who will get a different type of treatment called a flow diverter. This trial aims to improve how we diagnose and treat this challenging condition, and it hopes to provide clearer guidelines for doctors in the future. If you or a loved one is eligible and interested, you can consider joining this important research effort.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Age 18-80 years old;
• • 2. Patients diagnosis of "unruptured vertebrobasilar dissecting aneurysm".
• Exclusion Criteria:
• • 1. Patients did not undergo a cranial MRI;
• • 2. Missing critical clinical baseline;
• • 3. Missing pre-treatment imaging;
• • 4. Receiving microsurgery;
• • 5. The combination of other serious diseases during diagnosis will significantly affect the follow-up of patients;
• • 6. CT/MRI shows intracranial hemorrhage or subarachnoid hemorrhage (SWI microbleeds are ignored).